-
specific to the RefleXion linear accelerator. RefleXion is a novel radiation machine that delivers treatment using positron emission tomography (PET) guidance. As it is a new technology and our program is
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
diseases, shaping the future of medicine through cutting-edge research. The Schones lab at City of Hope is recruiting a Postdoctoral Fellow. Current projects in the lab are related to the epigenetic
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their
-
, shaping the future of medicine through cutting-edge research. The Schones lab at City of Hope is recruiting a Postdoctoral Fellow. Current projects in the lab are related to the epigenetic regulation
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their